Basic Information | Post buying leads | Suppliers |
Name |
Zylofuramine |
EINECS | N/A |
CAS No. | 3563-92-6 | Density | 1.006g/cm3 |
PSA | 21.26000 | LogP | 2.77710 |
Solubility | N/A | Melting Point |
N/A |
Formula | C14H21 N O | Boiling Point | 328.8°Cat760mmHg |
Molecular Weight | 219.36 | Flash Point | 137.2°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by subcutaneous and intravenous routes. Moderately toxic by ingestion. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Furfurylamine,a-benzyl-N-ethyltetrahydro-,D-threo- (8CI); D-threo-a-Benzyl-N-ethyltetrahydrofurfurylamine; Zylofuramine |
IUPAC Name: (1R)-N-Ethyl-1-[(2R)-oxolan-2-yl]-2-phenylethanamine
Empirical Formula: C14H21NO
Molecular Weight: 219.3226 g/mol
Index of Refraction: 1.523
Density: 1.006 g/cm3
Flash Point: 137.2 °C
Boiling Point: 328.8 °C at 760 mmHg
Vapour Pressure: 0.000185 mmHg at 25 °C
Structure of Zylofuramine (CAS NO.3563-92-6):
Zylofuramine (CAS NO.3563-92-6) has been used as a stimulant drug, and was developed in 1961. It was intended for use as an appetite suppressant and for the treatment of senile dementia in the elderly.
1. | orl-mus LD50:475 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 146 (1963),392. | ||
2. | scu-mus LD50:155 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 146 (1963),392. | ||
3. | ivn-mus LD50:32 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 146 (1963),392. |
Poison by subcutaneous and intravenous routes. Moderately toxic by ingestion. When heated to decomposition it emits toxic fumes of NOx.
Zylofuramine ,its cas register number is 3563-92-6. It also can be called D-threo-alpha-Benzyl-N-ethyltetrahydrofurfurylamine ; Furfurylamine, alpha-benzyl-N-ethyl-tetrahydro-, D-threo- ; and Zylofuraminum . Zylofuramine (CAS NO.3563-92-6) is legal throughout the world. Its chemical structure has a vague similarity to other N-ethyl substituted stimulant drugs such as ethylamphetamine.